Associated Papers
Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer.
Norton N et al.
Clinical and Translational Science, 2025
Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.
Zhang T et al.
Peerj, 2024
39465171 (PubMed )
Supplement: peerj-12-18360-s002.7z › drug-metabolizing_enzymes_and_transporter__DMET__microarray › markerlist.xlsx › markerlist.TXT
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform.
Kim B et al.
Translational and Clinical Pharmacology, 2021
34621706 (PubMed )
Supplement: tcp-29-135-s001.xls › tcp-29-135-s001
Genetics of androgen metabolism in women with infertility and hypoandrogenism.
Shohat-Tal A et al.
Nature Reviews. Endocrinology, 2015
Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.
Ginsberg G et al.
Critical Reviews in Toxicology, 2010
Genetic diversity and function in the human cytosolic sulfotransferases.
Hildebrandt MA et al.
The Pharmacogenomics Journal, 2007
Association of SULT2A1 allelic variants with plasma adrenal androgens and prostate cancer in African American men.
Wilborn TW et al.
The Journal of Steroid Biochemistry and Molecular Biology, 2006
Pharmacogenetics of human cytosolic sulfotransferases.
Nowell S et al.
Oncogene, 2006
Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies.
Thomae BA et al.
The Pharmacogenomics Journal, 2002
Sulfation through the looking glass--recent advances in sulfotransferase research for the curious.
Coughtrie MW
The Pharmacogenomics Journal, 2002
Select a paper to view details